These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1678578)

  • 1. Enhancement of the trypanocidal activity of methyltriazenes in an animal model by the addition of an amidino group.
    Buddhu S; Penketh PG; Divo AA; Shyam K; Patton CL; Sartorelli AC
    Acta Trop; 1991 Apr; 49(1):69-72. PubMed ID: 1678578
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimization of the pharmacokinetic properties of potent anti-trypanosomal triazine derivatives.
    Salado IG; Baán A; Verdeyen T; Matheeussen A; Caljon G; Van der Veken P; Kiekens F; Maes L; Augustyns K
    Eur J Med Chem; 2018 May; 151():18-26. PubMed ID: 29604541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biochemistry of African trypanosomes and its significance for chemotherapy.
    Braide VB
    J Vet Pharmacol Ther; 1987 Sep; 10(3):191-201. PubMed ID: 3309362
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective delivery of 2-hydroxy APA to Trypanosoma brucei using the melamine motif.
    Klee N; Wong PE; Baragaña B; Mazouni FE; Phillips MA; Barrett MP; Gilbert IH
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4364-6. PubMed ID: 20615694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships for new organometallic complexes active against bloodstream forms of Trypanosoma brucei brucei.
    Loiseau PM; Gutierrez-Rios MT; De Frutos MI; Craciunescu DG
    Parasitol Res; 2001 Jul; 87(7):566-9. PubMed ID: 11484855
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of experimental trypanocidal compounds against a multiple drug-resistant Trypanosoma brucei brucei stock in mice.
    Zweygarth E; Röttcher D
    Parasitol Res; 1989; 75(3):178-82. PubMed ID: 2710771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacomodulations on new organometallic complexes of Ir, Pt, Rh, Pd, Os: in vitro and in vivo trypanocidal study against Trypanosoma brucei brucei.
    Loiseau PM; Craciunescu DG; Doadrio-Villarejo JC; Certad-Fombona G; Gayral P
    Trop Med Parasitol; 1992 Jun; 43(2):110-4. PubMed ID: 1519021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New leads for trypanosomiasis chemotherapy.
    Lancet; 1978 Dec; 2(8101):1190. PubMed ID: 82152
    [No Abstract]   [Full Text] [Related]  

  • 9. IMOL 881, a new trypanocidal compound.
    Maes L; Songa EB; Hamers R
    Acta Trop; 1993 Sep; 54(3-4):261-9. PubMed ID: 7902663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prophylactic and curative action of Ridzol-S and Ronidazole in experimental trypanosomiasis caused by Trypanosoma brucei et T. evansi].
    Tchalim TK
    Ann Soc Belg Med Trop; 1980 Sep; 60(3):263-70. PubMed ID: 7195691
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness.
    Urbaniak MD; Tabudravu JN; Msaki A; Matera KM; Brenk R; Jaspars M; Ferguson MA
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5744-7. PubMed ID: 16962325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitrypanosomal effect of the aqueous extract of Brassica oleracea.
    Igweh AC; Aguiyi JC; Okwuasaba FK
    Fitoterapia; 2002 Feb; 73(1):17-21. PubMed ID: 11864758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanocidal activity of piperazine-linked bisbenzamidines and bisbenzamidoxime, an orally active prodrug.
    Huang TL; Bacchi CJ; Kode NR; Zhang Q; Wang G; Yartlet N; Rattendi D; Londono I; Mazumder L; Vanden Eynde JJ; Mayence A; Donkor IO
    Int J Antimicrob Agents; 2007 Dec; 30(6):555-61. PubMed ID: 17920820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-sleeping sickness drugs and cancer chemotherapy.
    Barrett SV; Barrett MP
    Parasitol Today; 2000 Jan; 16(1):7-9. PubMed ID: 10637579
    [No Abstract]   [Full Text] [Related]  

  • 15. The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes.
    Barrett MP; Fairlamb AH
    Parasitol Today; 1999 Apr; 15(4):136-40. PubMed ID: 10322334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanosome glucose transporters.
    Barrett MP; Tetaud E; Seyfang A; Bringaud F; Baltz T
    Mol Biochem Parasitol; 1998 Mar; 91(1):195-205. PubMed ID: 9574935
    [No Abstract]   [Full Text] [Related]  

  • 17. A drug resistance determinant in Trypanosoma brucei.
    Carter NS; Barrett MP; de Koning HP
    Trends Microbiol; 1999 Dec; 7(12):469-71. PubMed ID: 10603477
    [No Abstract]   [Full Text] [Related]  

  • 18. Spiroarsoranes of second generation: evaluation of trypanocidal properties against Trypanosoma brucei brucei.
    Loiseau PM; Wolf JG; Gayral P
    Trop Med Parasitol; 1993 Mar; 44(1):32-6. PubMed ID: 8516630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of combination of DFMO and diminazene aceturate in the treatment of late stage Trypanosoma brucei brucei infection in rats.
    Onyeyili PA; Onwualu JE
    Trop Med Parasitol; 1991 Jun; 42(2):143-5. PubMed ID: 1896772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do we need new drugs against human African trypanosomiasis?
    Stich A; Ponte-Sucre A; Holzgrabe U
    Lancet Infect Dis; 2013 Sep; 13(9):733-4. PubMed ID: 23969207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.